Melody Cobleigh to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Melody Cobleigh has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.035
-
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer. Clin Cancer Res. 2011 Jan 15; 17(2):372-81.
Score: 0.023
-
First-line Herceptin monotherapy in metastatic breast cancer. Oncology. 2001; 61 Suppl 2:37-42.
Score: 0.012